Spinocerebellar ataxia type 23 (SCA23): a review

被引:25
|
作者
Wu, Fan [1 ]
Wang, Xu [1 ]
Li, Xiaohan [1 ]
Teng, Huidi [1 ]
Tian, Tao [2 ]
Bai, Jing [1 ]
机构
[1] First Hosp Jilin Univ, Dept Neurol, Changchun 130021, Peoples R China
[2] First Hosp Jilin Univ, Dept Cardiol, Changchun 130021, Peoples R China
关键词
Spinocerebellar ataxia type 23; Prodynorphin; Clinical symptoms; Pathophysiological mechanisms; Epigenetics; Spinocerebellar ataxias; DOMINANT CEREBELLAR-ATAXIA; PRODYNORPHIN-DERIVED PEPTIDE; DYNORPHIN-A; HEREDITARY ATAXIAS; BIG DYNORPHIN; EPIGENETICS; MUTATIONS; MECHANISM; GENETICS; CURRENTS;
D O I
10.1007/s00415-020-10297-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinocerebellar ataxias (SCAs), formerly known as autosomal dominant cerebellar ataxias (ADCAs), are a group of hereditary heterogeneous neurodegenerative diseases. Gait, progressive ataxia, dysarthria, and eye movement disorder are common symptoms of spinocerebellar ataxias. Other symptoms include peripheral neuropathy, cognitive impairment, psychosis, and seizures. Patients may lose their lives due to out of coordinated respiration and/or swallowing. Neurological signs cover pyramidal or extrapyramidal signs, spasm, ophthalmoplegia, hyperactive deep tendon reflexes, and so on. Different subtypes of SCAs present various clinical features. Spinocerebellar ataxia type 23 (SCA23), one subtype of the SCA family, is characterized by mutant prodynorphin (PDYN) gene. Based on literatures, this review details a series of SCA23, to improve a whole understanding of clinicians and point out the potential research direction of this dysfunction, including a history, pathophysiological mechanism, diagnosis and differential diagnosis, epigenetics, penetrance and prevalence, genetic counseling, treatment and prognosis.
引用
收藏
页码:4630 / 4645
页数:16
相关论文
共 50 条
  • [1] Spinocerebellar ataxia type 23 (SCA23): a review
    Fan Wu
    Xu Wang
    Xiaohan Li
    Huidi Teng
    Tao Tian
    Jing Bai
    Journal of Neurology, 2021, 268 : 4630 - 4645
  • [2] The Novel Mutation Spinocerebellar Ataxia (SCA23) with Head Tremor in Japanese Family
    Saigoh, Kazumasa
    Mitsui, Jun
    Hirano, Makito
    Sioyama, Mitsuaki
    Ichikawa, Yaeko
    Goto, Jun
    Tsuji, Shoji
    Kusunoki, Susumu
    ANNALS OF NEUROLOGY, 2014, 76 : S47 - S47
  • [3] Spinocerebellar ataxia type 23 is an uncommon SCA subtype in the Chinese Han population
    Liu, Yu-Tao
    Tang, Bei-Sha
    Wang, Jun-Ling
    Guan, Wen-Juan
    Shen, Lu
    Shi, Yu-Ting
    Zhou, Ying
    Yan, Xin-Xiang
    Xia, Kun
    Jiang, Hong
    NEUROSCIENCE LETTERS, 2012, 528 (01) : 51 - 54
  • [4] Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe
    Schicks, J.
    Synofzik, M.
    Beetz, C.
    Schiele, F.
    Schoels, L.
    CLINICAL GENETICS, 2011, 80 (05) : 503 - 504
  • [5] Spinocerebellar Ataxia Type 23: A Genetic Update
    Verbeek, Dineke S.
    CEREBELLUM, 2009, 8 (02): : 104 - 107
  • [6] Spinocerebellar Ataxia Type 23: A Genetic Update
    Dineke S. Verbeek
    The Cerebellum, 2009, 8 : 104 - 107
  • [7] SCA23 and prodynorphin: is it time for gene retraction?
    Pedroso, Jose Luiz
    Vale, Thiago Cardoso
    Freua, Fernando
    Barsottini, Orlando G. P.
    Kok, Fernando
    BRAIN, 2016, 139
  • [8] The frequency of spinocerebellar ataxia type 23 in a UK population
    Fawcett, Katherine
    Mehrabian, Mohadeseh
    Liu, Yo-Tsen
    Hamed, Sherifa
    Elahi, Elahe
    Revesz, Tamas
    Koutsis, Georgios
    Herscheson, Joshua
    Schottlaender, Lucia
    Wardle, Mark
    Morrison, Patrick J.
    Morris, Huw R.
    Giunti, Paola
    Wood, Nicholas
    Houlden, Henry
    JOURNAL OF NEUROLOGY, 2013, 260 (03) : 856 - 859
  • [9] Reply: SCA23 and prodynorphin: is it time for gene retraction?
    Smeets, Cleo J. L. M.
    Verbeek, Dineke S.
    BRAIN, 2016, 139
  • [10] SCA23: From likely pathogenic to rare polymorphism
    Garcia Solaesa, V.
    Bengoa Alonso, A.
    Lizarraga Rojas, M. T.
    Echeverria Sadaba, L.
    Artigas Lopez, M.
    Andueza Otsoa, E.
    Harou, A.
    Alvarez Iriarte, Y.
    Martinez Rey, M. M.
    Ramos Arroyo, M. A.
    CLINICA CHIMICA ACTA, 2019, 493 : S568 - S569